baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Journey Medical Corp/ US48115J1097 /

4/29/2024 9:45:44 PM	Chg. -0.06	Volume	Bid-	Ask-	High	Low
3.38USD	-1.74%	427 Turnover: 1,435.09	-Bid Size: -	-Ask Size: -	3.42	3.33

GlobeNewswire 4/25 Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire 3/28 Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire 3/21 Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire 3/18 Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the...

GlobeNewswire 3/15 Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

GlobeNewswire 3/13 Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

GlobeNewswire 3/11 Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the...

GlobeNewswire 2/14 Ocuphire Pharma Strengthens Leadership Team with Key Appointments

GlobeNewswire 1/5 Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

GlobeNewswire 1/2 Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

GlobeNewswire 12/6/2023 Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-...

GlobeNewswire 11/14/2023 Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire 11/7/2023 Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highli...

GlobeNewswire 10/31/2023 Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

GlobeNewswire 10/20/2023 Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydroch...

GlobeNewswire 9/6/2023 Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbr...

GlobeNewswire 3/28/2022 Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights

GlobeNewswire 3/23/2022 Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights

GlobeNewswire 3/18/2022 Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update ...

GlobeNewswire 3/17/2022 Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-2...

GlobeNewswire 3/9/2022 Journey Medical Corporation to Present at the 34th Annual ROTH Conference

GlobeNewswire 2/11/2022 QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2...

GlobeNewswire 1/13/2022 VYNE Therapeutics Divests Topical Minocycline Assets

GlobeNewswire 1/13/2022 Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stab...

GlobeNewswire 12/10/2021 Journey Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highli...

Journey Medical Corp/ US48115J1097 /

If you wish to receive reply to your feedback, please provide your email address.